Two years after a push for more transparency in the costs of insulin for diabetes treatment, state Sen. Yvanna Cancela is hoping to shed even more light on prescription drug prices and the health care system in Nevada
2019 Legislature
MOST READ: POLITICS & GOVT
1
2
3
4
5
Expect 100-degree heat at Trump rally in Las Vegas; caution urged
‘A really great thing’: New bridge links Laughlin, Bullhead City
‘Not your recreational shoplifting’: Feds putting more heat on organized retail theft
Nevada’s early voting turnout low ahead of June 11 primary
‘The government is broken’: Businesswoman vying to become Las Vegas’ next mayor